Anne S. Siebuhr

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.

Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.

Journal: RMD open

Published: May 10, 2023

Fibroblasts are not just fibroblasts: clear differences between dermal and pulmonary fibroblasts' response to fibrotic growth factors.

Fibroblasts are not just fibroblasts: clear differences between dermal and pulmonary fibroblasts' response to fibrotic growth factors.

Journal: Scientific reports

Published: February 20, 2023

Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?

Objective and noninvasive biochemical markers in rheumatoid arthritis: where are we and where are we going?

Journal: Expert review of proteomics

Published: March 30, 2021

Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum.

Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum.

Journal: Osteoarthritis and cartilage open

Published: January 29, 2021

Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.

Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.

Journal: Rheumatology international

Published: December 03, 2020

Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.

Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.

Journal: Scientific reports

Published: August 21, 2020

The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo.

The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo.

Journal: International journal of molecular sciences

Published: July 01, 2020

Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study.

Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study.

Journal: Arthritis research & therapy

Published: June 29, 2020

Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis.

Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis.

Journal: Scientific reports

Published: June 04, 2020

Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study.

Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study.

Journal: The Lancet. Rheumatology

Published: April 17, 2020

Type III, IV, and VI Collagens Turnover in Systemic Sclerosis - a Longitudinal Study.

Type III, IV, and VI Collagens Turnover in Systemic Sclerosis - a Longitudinal Study.

Journal: Scientific reports

Published: January 24, 2020

Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivo.

Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivo.

Journal: Scientific reports

Published: December 09, 2019

Showing 1-12 of 49

Last Updated: 09/26/2026